The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer
Clinical trial NCT00295750 · COMPLETED
Trial details
- NCT number
- NCT00295750
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2007-10-01
- Enrollment
- 620
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.